Protein Requirements in Adults With Phenylketonuria (PKU)

Status Recruiting

Clinical Trial Summary

Phenylketonuria (PKU) is an inherited inborn error of phenylalanine (PHE) metabolism caused by decreased activity of phenylalanine hydroxylase (PAH) enzyme. Therefore, PHE accumulates in plasma leading to mental problems. Treatment is a phenylalanine-restricted diet with sufficient protein. However, the optimum protein requirements are still unknown and compliance with diet is not satisfactory in PKU adults. A Previously established technique called indicator amino acid oxidation (IAAO) will be used to determine protein requirements from amino acid based formula vs. glycomacropeptide (GMP) in adults with PKU (≥ 19y). This study will help treat adults with enough protein ensuring maintenance of health.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03939052
Study type	Interventional
Source	University of British Columbia
Contact	Rajavel Elango, PhD
Phone	604-875-2000
Email	relango@bcchr.ubc.ca
Status	Recruiting
Phase	N/A
Start date	July 19, 2019
Completion date	May 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05099640` - A Study of PTC923 in Participants With Phenylketonuria	Phase 3
Completed	`NCT01924026` - Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study	N/A
Completed	`NCT01428258` - Phase 2 Study of Glycomacropeptide Versus Amino Acid Diet for Management of Phenylketonuria	N/A
Completed	`NCT00925054` - Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU	Phase 2
Completed	`NCT00778206` - PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Recruiting	`NCT05948020` - Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria	N/A
Recruiting	`NCT05781399` - First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria	Phase 1
Completed	`NCT02555579` - Simplified Diet Approach in Phenylketonuria	N/A
Completed	`NCT03097250` - MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria
Completed	`NCT01965912` - Kuvan®'s Effect on the Cognition of Children With Phenylketonuria	Phase 4
Completed	`NCT01965691` - Protein Requirements in Children With Phenylketonuria (PKU)	N/A
Completed	`NCT00789568` - A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects	Phase 1
Completed	`NCT00688844` - Nutritional and Neurotransmitter Changes in PKU Subjects on BH4	N/A
Terminated	`NCT01465100` - Liver Cell Transplant for Phenylketonuria	Phase 1/Phase 2
Completed	`NCT01732471` - Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria	Phase 3
Completed	`NCT04879277` - Study of Low-grade Systemic Inflammation in Adult Patients With Phenylketonuria	N/A
Completed	`NCT02176603` - Observational Study of Endothelial Dysfunction in Phenylketonuria	N/A
Completed	`NCT01819727` - An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165	Phase 3
Completed	`NCT01869972` - Biological Variation of Phenylalanine in Patients With Hyperphenylalaninemia	N/A
Terminated	`NCT01904708` - Moderate Intensity Exercise and Phenylketonuria	N/A